Top 10 Early Analyst Upgrades & Downgrades (FUL, OZM, REP, TOL, DOV, EMR, GA, GSK, MEDX, RDS-A)

Print Email

These are ten of the top pre-market early bird upgrades and downgrades we are seeing from analysts this Friday morning:

  • H.B. Fuller (NYSE: FUL) Raised to Overweight at JPMorgan.
  • Och-Ziff Capital (NYSE: OZM) Started as Buy at Jefferies.
  • Repsol YPF (NYSE: REP) Raised to Buy from Hold at ING; Raised to Hold from Sell at Soc-Gen.
  • Toll Brothers (NYSE: TOL) Started as Outperform at KBW.
  • Dover (NYSE: DOV) Cut to Underweight at JPMorgan.
  • Emerson Electric (NYSE: EMR) Cut to Underweight at JPMorgan.
  • Giant Interactive (NYSE: GA) Cut to Perform at Oppenheimer.
  • GlaxoSmithkline (NYSE: GSK) Cut to Neutral from Buy at UBS.
  • Medarex (NASDAQ: MEDX) Started as Sell at Merriman Curhan Ford.
  • Royal Dutch Shell (NYSE: RDS-A) Cut to Hold from Buy at ING.

Jon C. Ogg
November 14, 2008